Scientific Breakthrough Identifies Python Blood Compound That Triggers Weight Loss Without Common Drug Side Effects

CU Boulder researchers discover pTOS in python blood, a compound that suppresses appetite without the nausea or muscle loss caused by current weight loss drugs.

By: AXL Media

Published: Mar 19, 2026, 10:56 AM EDT

Source: Information for this report was sourced from University of Colorado at Boulder

Harnessing Nature’s Most Extreme Metabolic Superpowers

A collaborative research effort between the University of Colorado Boulder, Stanford, and Baylor universities has uncovered an extraordinary appetite-suppressing molecule within the biology of pythons. These reptiles possess a unique ability to consume massive prey and subsequently endure months of fasting while maintaining perfect metabolic health and muscle mass. Senior author Leslie Leinwand, a distinguished professor who has studied the species for two decades, noted that the heart of a python can expand by 25% and its metabolism can surge 4,000-fold during digestion. This extreme biological flexibility provided the roadmap for identifying a compound that could eventually revolutionize human weight management.

The Discovery of the pTOS Metabolite

By analyzing blood samples from ball and Burmese pythons, the scientific team identified 208 distinct metabolites that spike immediately following a meal. The most significant finding was the molecule para-tyramine-O-sulfate (pTOS), which increased 1,000-fold in the snakes' systems after eating. According to Jonathan Long, an associate professor at Stanford University, studying such metabolic extremes in nature allows researchers to look far beyond the limitations of traditional human or mouse models. The research indicates that this specific molecule is produced by the snake's gut bacteria and plays a critical role in signaling satiety to the brain.

A New Frontier for Obesity Treatment

The implications for human health became clear during further testing conducted with researchers at Baylor University. When high doses of pTOS were administered to mice, the compound acted directly on the hypothalamus, the brain's primary appetite center. Unlike current blockbuster drugs such as Ozempic and Wegovy, which can cause significant gastrointestinal distress and unwanted muscle depletion, pTOS prompted weight loss without these adverse effects. Leinwand emphasized that this discovery offers a potential alternative for the millions of people who currently struggle with the side effects of GLP-1 receptor agonists.